Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates

Pharmacotherapy

Volumn 29, Issue 11, 2009, Pages 1297-1305

  Hoff, David S ^a   Wilcox, Roger A ^a   Tollefson, Lisa M ^a   Lipnik, Polina G ^a   Commers, Amy R ^a   Liu, Meixia ^a  

^a Children's Hospitals   (United States)

Author keywords

Aminoglycosides; Dosing; Gentamicin; Infectious disease; Neonate; Neonatology; Pharmacokinetics; Protocol

Indexed keywords

CREATININE; GENTAMICIN; INDOMETACIN;

ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG HALF LIFE; GESTATIONAL AGE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MAXIMUM PLASMA CONCENTRATION; MEDICAL RECORD REVIEW; NEWBORN; NEWBORN SEPSIS;

ANTI-BACTERIAL AGENTS; BIRTH WEIGHT; CRITICAL ILLNESS; DRUG ADMINISTRATION SCHEDULE; GENTAMICINS; GESTATIONAL AGE; HALF-LIFE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 70350514232     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.29.11.1297     Document Type: Article

References (63)

1. Reed MD, Besunder JB. Developmental pharmacology: ontogenic basis of drug disposition. Pediatr Clin N Am 1989;36:1053-1074
2. Paap CM, Nahata MC. Clinical pharmacokinetics of antibacterial drugs in neonates. Clin Pharmacokinet 1990;19:280-318.
3. Boyle EM, Brookes I, Nye K, Watkinson M, Riordan FAI. "Random" gentamicin concentrations do not predict trough levels in neonates receiving once-daily fixed dose regimens. BMC Pediatrics 2006;6:1-7.
4. García B, Barcia E, Pérez F, Molina IT. Population pharmacokinetics of gentamicin in premature newborns. J Antimicrob Chemother 2006;58:372-379 (Pubitemid 44294950)
5. Young TE, Mangum B. NEOFAX. Montvale, NJ: Thompson Reuters, 2008:42-43
6. Tugay S, Bircan Z, Çaglayan Ç, Arisoy AE, Gökalp AS. Acute effects of gentamicin on glomerular and tubular functions in preterm neonates. Pediatr Nephrol 2006;21:1389-1392 (Pubitemid 44283469)
7. Kosalaraksa P, Janthep P, Jirapradittha J, Taksaphan S, Kiatchoosakun P. Once- versus twice-daily dose of gentamicin therapy in Thai neonates. J Med Assoc Thai 2004;87:372-376 (Pubitemid 38744505)
8. Hale LS, Durham CR. A simple, weight-based, extended-interval gentamicin dosage protocol for neonates. Am J Health-Syst Pharm 2005;62:1613-1616
9. DiCenzo R, Forrest A, Slish JC, Cole C, Guillet R. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates. Pharmacotherapy 2003;23:585-591 (Pubitemid 36539039)
10. Avent ML, Kinney JS, Istre GR, Whitfield JM. Gentamicin and tobramycin in neonates: comparison of a new extended dosing interval regimen with a traditional multiple daily dosing regimen. Am J Perinatol 2002;19:413-419
11. Isemann BT, Kotagal UR, Mashni SM, Luckhaupt EJ, Johnson CJ. Optimal gentamicin therapy in preterm neonates includes loading doses and early monitoring. Ther Drug Monit 1996;18:549-555
12. Stickland MD, Kirkpatrick CMJ, Begg EJ, Duffull SB, Oddie SJ, Darlow BA. An extended interval dosing method for gentamicin in neonates. J Antimicrob Chemother 2001;48:887-893
13. Rocha MJ, Almeida AM, Afonso E, et al. The kinetic profile of gentamicin in premature neonates. J Pharm Pharmacol 2000;52:1091-1097 (Pubitemid 30742020)
14. Ohler KH, Menke JA, Fuller L. Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit. Am J Perinatol 2000;17:285-290 (Pubitemid 32043899)
15. Brion LP, Fleischman AR, Schwartz GJ. Gentamicin interval in newborn infants as determined by renal function and postconceptional age. Pediatr Nephrol 1991;5:675-678
16. Weber W, Kewitz, Rost KL, Looby M, Nitz, Harnisch L. Population kinetics of gentamicin in neonates. Eur J Clin Pharmacol 1993;44(suppl 1):S23-5.
17. Moore RD, Leitman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987;155:93-99
18. Skopnik H, Wallraf R, Nies B, Tröster K, Heimann G. Pharmacokinetics and antibacterial activity of daily gentamicin. Arch Dis Child 1992;67:57-61.
19. Noone P, Parsons TMC, Pattison JR, Slack RCB, Garfield-Davies D, Hughes K. Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J 1974;1:477-481
20. Moore RD, Smith CR, Lietman PS. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis 1984;149:443-448 (Pubitemid 14138249)
21. Moore RD, Smith CR, Lietman PS. Association of aminoglycoside plasma levels with therapeutic outcome in gramnegative pneumonia. Am J Med 1984;77:657-662 (Pubitemid 14047595)
22. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987;155:93-99
23. Noone P, Pattison JR. The effective use of gentamicin in life-threatening sepsis. Postgrad Med J 1974;50(suppl 7):9-16.
24. Matz GJ. Aminoglycoside cochlear ototoxicity. Otolaryngol Clin N Am 1993;26:705-712
25. Haughey DB, Hilligoss DM, Grassi A, Schentag JJ. Two-compartment gentamicin pharmacokinetics in premature neonates: a comparison to adults with decreased glomerular filtration rates. J Pediatr 1980;96:325-330 (Pubitemid 10129433)
26. Aust G. Vestibulotoxicity and ototoxicity of gentamicin in newborns at risk. Int Tinnitus J 2001;7:27-29 (Pubitemid 34056608)
27. McCracken GH. Aminoglycoside toxicity in infants and children. Am J Med 1986;80(suppl 6B):172-177
28. De Cos MA, Gomez-Ullate J, Gomez F, et al. Time course of trough serum gentamicin concentrations in preterm and term neonates. Clin Pharmacokinet 1992;23:391-401.
29. Fisk KL. A review of gentamicin use in neonates. Neonatal Netw 1993;12:19-23.
30. Giapros VI, Andronikou S, Cholevas VI, Papadopolou ZL. Renal function in premature infants during aminoglycoside therapy. Pediatr Nephrol 1995;9:163-166 (Pubitemid 26401946)
31. Andronikou S, Giapros VI, Cholevas VI, Papadopolou ZL. Effect of aminoglycoside therapy on renal function in fullterm infants. Pediatr Nephrol 1996;10:766-768 (Pubitemid 26401946)
32. Giapros VI, Andronikou SK, Cholevas VI, Papadopolou ZL. Renal function and effect of aminoglycoside therapy during the first ten days of life. Pediatr Nephrol 2003;18:46-52.
33. Giapros VI, Cholevas VI, Andronikou SK. Acute effects of gentamicin on urinary electrolyte excretion in neonates. Pediatr Nephrol 2004;19:322-325
34. Dahlgren JD, Anderson ET, Hewitt WL. Gentamicin blood levels: a guide to nephrotoxicity. Antimicrob Agent Chemother 1975;8:58-62.
35. Edelmann CM Jr, Bernstein J, Meadow SR, Spitzer A, Travis LB, eds. Pediatric kidney disease. Boston: Little, Brown and Company, 1992.
36. Sawchuk RJ, Zaske DE. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients. J Pharmacokinet Biopharm 1976;4:183-195
37. Husson C, Chevalier JY, Jezequel M, Mathe JC, Costil J, Aymard P. Pharmacokinetic study of gentamicin in preterm and term neonates. Dev Pharmacol Ther 1984;7(suppl 1):125-129 (Pubitemid 15224712)
38. Alsaedi SA. Once-daily gentamicin dosing in full-term neonates. Saudi Med J 2003;24:978-981
39. Agarwal G, Rastogi A, Pyati S, Wilks A, Pildes RS. Comparison of once-daily versus twice-daily gentamicin dosing regimens in infants ≥ 2500 g. J Perinatol 2002;22:268-274 (Pubitemid 34619097)
40. Rastogi A, Agarwal G, Pyati S, Pildes R. Comparison of two gentamicin dosing schedules in very low birth weight infants. Pediatr Infect Dis J 2002;21:234-240 (Pubitemid 34214141)
41. Mercado CK, Brodsky NL, McGuire MK, Hurt H. Extended-interval dosing of gentamicin in preterm infants. Am J Perinatol 2004;21:73-77 (Pubitemid 38269479)
42. Lundergan FS, Glasscock GF, Kim EH, Cohen RS. Once-daily gentamicin dosing in newborn infants. Pediatrics 1999;103:1228-1234
43. de Alba Romero C, Gómez Castillo E, Manzanares Secades C, Rodriguez López J, Arraeza López L, Saenz Valiente P. Once-daily gentamicin dosing in neonates. Pediatr Infect Dis J 1998;17:1169-1171
44. Kiatchoosakun P, Kosalaraksa P, Jirapradittha J, Taksaphan S, Tassniyom S. Once-daily gentamicin dosing of 4 mg/kg/dose in neonates. J Med Assoc Thai 2005;88:934-938 (Pubitemid 41337702)
45. Hayani KC, Hatzopoulos FK, Frank AL, et al. Pharmacokinetics of once-daily dosing of gentamicin in neonates. J Pediatr 1997;131:76-80. (Pubitemid 27498312)
46. Mulhall A, de Louvois J, Hurley R. Incidence of potentially toxic concentrations of gentamicin in the neonate. Arch Dis Child 1983;58:897-900. (Pubitemid 14240958)
47. Thingvoll ES, Guillet R, Caserta M, DiCenzo R. Observational trial of a 48-hour gentamicin dosing regimen derived from Monte Carlo simulations in infants born at less than 28 weeks' gestation. J Pediatr 2008;153:530-534
48. Hansen A, Forbes P, Arnold A, O'Rourke E. Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels. J Perinatol 2003;23:635-639 (Pubitemid 37541003)
49. Thureen P, Reiter P, Gresores A, Stolpman N, Kawato K, Hall D. Once- versus twice-daily gentamicin dosing in neonates ≥ 34 weeks' gestation: cost-effectiveness analyses. Pediatrics 1999;103:594-598 (Pubitemid 29274506)
50. Langlass TM, Mickle TR. Standard gentamicin dosage regimen in neonates. Am J Health-Syst Pharm 1999;56:440-443
51. Vervelde ML, Rademaker CMA, Krediet TG, Fleer A, van Asten P, van Dijk A. Population pharmacokinetics of gentamicin in preterm neonates: evaluation of a once-daily dosage regimen. Ther Drug Monit 1999;21:514-519 (Pubitemid 29468317)
52. Capers CC, Gregory DF, Herzog CC, Walsh W, Watson B. Optimal gentamicin dosing in neonates. Ann Pharmacother 1995;29:430-431
53. Faura CC, Feret MA, Horga JF. Monitoring serum levels of gentamicin to develop a new regimen for gentamicin dosage in newborns. Ther Drug Monit 1991;13:268-276
54. Bloome MR, Warren AJ, Ringer L, Walker PC. Evaluation of an empirical dosing schedule for gentamicin in neonates. Drug Intel Clin Pharm 1988;22:618-622 (Pubitemid 18203430)
55. Miranda JC, Schimmel MM, James LS, Spinelli W, Rosen TS. Gentamicin kinetics in the neonate. Pediatr Pharmacol 1985;5:57-61.
56. Edgren B, Karna P, Sciamanna D, Dolanski E. Gentamicin dosing in the newborn: use of a one-compartment open pharmacokinetic model to individualize dosing. Dev Pharmacol Ther 1984;7:263-272 (Pubitemid 14116892)
57. Hindmarsh KW, Nation RL, Williams GL, John E, French JN. Pharmacokinetics of gentamicin in very low birth weight preterm infants. Eur J Clin Pharmacol 1983;24:649-653
58. Glover ML, Shaffer CL, Rubino CM, et al. A multicenter evaluation of gentamicin therapy in the neonatal intensive care unit. Pharmacotherapy 2001;21:7-10. (Pubitemid 32047573)
59. Murphy JE, Austin ML, Frye RF. Evaluation of gentamicin pharmacokinetics and dosing protocols in 195 neonates. Am J Health-Syst Pharm 1998;55:2280-2288 (Pubitemid 28510086)
60. Krishnan L, George SA. Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatr 1997;34: 1075-1080 (Pubitemid 28035930)
61. Jerome M, Davis JC. The effects of indomethacin on gentamicin serum levels. Proc West Pharmacol Soc 1987;30:85-87 (Pubitemid 17132692)
62. Keyes PS, Johnson CK, Rawlins TD. Predictors of trough serum gentamicin concentrations in neonates. Am J Dis Child 1989;143:1419-1423
63. Knight JA, Davis EM, Manouilov K, Hoie EB. The effect of postnatal age on gentamicin pharmacokinetics in neonates. Pharmacotherapy 2003;23:992-996 (Pubitemid 36904000)